These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33636166)

  • 1. Suppression of α-synuclein propagation after intrastriatal injection in FABP3 null mice.
    Matsuo K; Kawahata I; Melki R; Bousset L; Owada Y; Fukunaga K
    Brain Res; 2021 Jun; 1760():147383. PubMed ID: 33636166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain.
    Yabuki Y; Matsuo K; Kawahata I; Fukui N; Mizobata T; Kawata Y; Owada Y; Shioda N; Fukunaga K
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of MPTP-induced α-synuclein oligomerization by fatty acid-binding protein 3 ligand in MPTP-treated mice.
    Matsuo K; Cheng A; Yabuki Y; Takahata I; Miyachi H; Fukunaga K
    Neuropharmacology; 2019 May; 150():164-174. PubMed ID: 30930168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crucial Role of FABP3 in αSyn-Induced Reduction of Septal GABAergic Neurons and Cognitive Decline in Mice.
    Matsuo K; Yabuki Y; Melki R; Bousset L; Owada Y; Fukunaga K
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An α-synuclein decoy peptide prevents cytotoxic α-synuclein aggregation caused by fatty acid binding protein 3.
    Fukui N; Yamamoto H; Miyabe M; Aoyama Y; Hongo K; Mizobata T; Kawahata I; Yabuki Y; Shinoda Y; Fukunaga K; Kawata Y
    J Biol Chem; 2021; 296():100663. PubMed ID: 33862084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of FABP3 ligands that inhibit arachidonic acid-induced α-synuclein oligomerization.
    Cheng A; Shinoda Y; Yamamoto T; Miyachi H; Fukunaga K
    Brain Res; 2019 Mar; 1707():190-197. PubMed ID: 30496735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel FABP3 ligand, HY-11-9, ameliorates neuropathological deficits in MPTP-induced Parkinsonism in mice.
    Wang H; Fukunaga K; Cheng A; Wang Y; Arimura N; Yoshino H; Sasaki T; Kawahata I
    J Pharmacol Sci; 2023 May; 152(1):30-38. PubMed ID: 37059489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FABP3 protein promotes α-synuclein oligomerization associated with 1-methyl-1,2,3,6-tetrahydropiridine-induced neurotoxicity.
    Shioda N; Yabuki Y; Kobayashi Y; Onozato M; Owada Y; Fukunaga K
    J Biol Chem; 2014 Jul; 289(27):18957-65. PubMed ID: 24855640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty Acid-Binding Protein 3 is Critical for α-Synuclein Uptake and MPP
    Kawahata I; Bousset L; Melki R; Fukunaga K
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. α-Synuclein decoy peptide protects mice against α-synuclein-induced memory loss.
    Guo Q; Kawahata I; Jia W; Wang H; Cheng A; Yabuki Y; Shioda N; Fukunaga K
    CNS Neurosci Ther; 2023 Jun; 29(6):1547-1560. PubMed ID: 36786129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of fatty acid-binding proteins and dopamine receptors on α-synucleinopathy.
    Kawahata I; Fukunaga K
    J Pharmacol Sci; 2022 Feb; 148(2):248-254. PubMed ID: 35063140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model.
    Underwood R; Gannon M; Pathak A; Kapa N; Chandra S; Klop A; Yacoubian TA
    Acta Neuropathol Commun; 2021 Jan; 9(1):13. PubMed ID: 33413679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein.
    Merghani MM; Ardah MT; Al Shamsi M; Kitada T; Haque ME
    Neurotoxicology; 2021 May; 84():41-52. PubMed ID: 33549656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty Acid-Binding Protein 3 Expression in the Brain and Skin in Human Synucleinopathies.
    Oizumi H; Yamasaki K; Suzuki H; Hasegawa T; Sugimura Y; Baba T; Fukunaga K; Takeda A
    Front Aging Neurosci; 2021; 13():648982. PubMed ID: 33841128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers.
    Boi L; Pisanu A; Palmas MF; Fusco G; Carboni E; Casu MA; Satta V; Scherma M; Janda E; Mocci I; Mulas G; Ena A; Spiga S; Fadda P; De Simone A; Carta AR
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease.
    Jimenez-Ferrer I; Bäckström F; Dueñas-Rey A; Jewett M; Boza-Serrano A; Luk KC; Deierborg T; Swanberg M
    Brain Behav Immun; 2021 Jan; 91():369-382. PubMed ID: 33223048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathology of α-synuclein in Parkinson's disease.
    Choong CJ; Mochizuki H
    Neuropathology; 2022 Apr; 42(2):93-103. PubMed ID: 35362115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rab7 reduces α-synuclein toxicity in rats and primary neurons.
    Szegö EM; Van den Haute C; Höfs L; Baekelandt V; Van der Perren A; Falkenburger BH
    Exp Neurol; 2022 Jan; 347():113900. PubMed ID: 34695425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degeneration.
    Paumier KL; Luk KC; Manfredsson FP; Kanaan NM; Lipton JW; Collier TJ; Steece-Collier K; Kemp CJ; Celano S; Schulz E; Sandoval IM; Fleming S; Dirr E; Polinski NK; Trojanowski JQ; Lee VM; Sortwell CE
    Neurobiol Dis; 2015 Oct; 82():185-199. PubMed ID: 26093169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.